文献速递眼底病与葡萄膜炎

糖尿病黄斑水肿合并非增殖期糖尿病视网膜病变眼失访后持续视力丧失的相关因素

FACTORS ASSOCIATED WITH PERSISTENT VISION LOSS IN EYES WITH DIABETIC MACULAR EDEMA AND NONPROLIFERATIVE DIABETIC RETINOPATHY AFTER LOST-TO-FOLLOW-UP.
PubMed 文献 · Retina · 2026-01-01

该回顾性研究纳入169只眼,均曾接受抗VEGF注射、失访超过6个月后返回治疗并随访至少12个月。约38%的眼在返回时视力较失访前下降≥10个字母,12个月时27.2%的眼持续下降≥10个字母。White种族与12个月视力下降风险降低相关,返回时视力及中心凹厚度与视力丧失相关。

要点

  • 失访后返回的眼约38%出现≥10字母视力下降,12个月时27.2%持续下降。
  • White种族与12个月视力下降风险降低相关(OR 0.42)。
  • 返回时视力较差及中心凹厚度增加与视力丧失相关。

核心结论

  • 约1/4的眼在恢复治疗1年后仍存在持续视力丧失。
  • 种族和失访后返回时的视力与12个月视力丧失相关。
  • 返回时黄斑水肿加重与返回时视力丧失相关。

研究设计与样本

  • 回顾性研究,于2015年1月1日至2023年1月1日在Wills Eye Hospital/Mid Atlantic Retina进行。
  • 纳入标准:失访前至少1次抗VEGF注射、失访超过6个月、返回后随访至少12个月。
  • 共纳入169例患者的169只眼。

主要发现

  • 约38%(64/169)的眼在返回时视力较失访前下降≥10个字母。
  • 返回后12个月,27.2%(46/169)的眼视力较失访前基线持续下降≥10个字母。
  • 多变量分析中,White种族与12个月随访时≥10字母视力下降可能性降低相关(OR 0.42,95%CI:0.20-0.92,P=0.03)。
  • 返回时视力与12个月视力丧失相关(OR 6.47,95%CI:1.96-21.33,P=0.002)。
  • 返回时中心凹厚度增加是唯一与返回时≥10字母视力丧失相关的因素(OR 1.004,95%CI:1.001-1.007,P=0.012)。

临床怎么用

  • 对糖尿病黄斑水肿合并非增殖期糖尿病视网膜病变患者,应重视失访后返回时的视力评估和黄斑水肿控制。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine factors associated with persistent vision loss among eyes with nonproliferative diabetic retinopathy and diabetic macular edema who return to care after loss to follow-up (LTFU). METHODS: This retrospective study was conducted at the Wills Eye Hospital/Mid Atlantic Retina between January 1st, 2015 and January 1st, 2023. Patients were included if they met the following study inclusion criteria (1) ≥1 anti-vascular endothelial growth factor injection before LTFU; (2) history of LTFU for >6 months; (3) returned for care with ≥12 months of follow-up after LTFU. RESULTS: A total of 169 eyes of 169 patients met our inclusion criteria. Approximately 38% of eyes (N = 64/169) worsened after returning to care, with ≥10-letter decline in visual acuity compared with their pre-LTFU visit. At 12 months postreturn, 27.2% (N = 46/169) had a persistent ≥10-letter decrease in visual acuity from their pre-LTFU baseline. On multivariable analysis, White race (OR 0.42, 95% CI: 0.20-0.92, P = 0.03) was associated with decreased likelihood of ≥10-letter loss at the 12-month follow-up visit. Visual acuity at time of return (OR 6.47, 95% CI: 1.96-21.33, P = 0.002) was also associated with vision loss at the 12-month visit. Increasing central foveal thickness at time of return (OR 1.004, 95% CI: 1.001-1.007, P = 0.012) was the only factor associated with a ≥10-letter loss at the return visit. CONCLUSION: Approximately 1/4th of eyes had persistent vision loss at 1-year despite resumption of treatment. Race and visual acuity upon return after LTFU were associated with vision loss at the 12-month visit. Increased macular edema was associated with vision loss at return visit.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Zafar S, Momenaei B, Kim I, et al. FACTORS ASSOCIATED WITH PERSISTENT VISION LOSS IN EYES WITH DIABETIC MACULAR EDEMA AND NONPROLIFERATIVE DIABETIC RETINOPATHY AFTER LOST-TO-FOLLOW-UP. Retina. 2026. PMID: 42212937. doi:10.1097/IAE.0000000000004892

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。